National Institute of Diabetes and Digestive and Kidney Diseases Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting, 43694-43695 [2011-18422]
Download as PDF
<![CDATA[
43694
Federal Register / Vol. 76, No. 140 / Thursday, July 21, 2011 / Notices
submissions, the Center will generally
specify an additional amount of time for
sponsors of those submissions to
address the new issues. Where
appropriate, ‘‘Notice to Industry’’
Guidance Letters would be followed as
quickly as possible by new or revised
guidance explaining the Center’s new
regulatory expectations (if any) in
greater detail and revising the guidance
where necessary in response to
comments received, so that external
constituencies have a fuller
understanding of the Center’s current
regulatory thinking.
II. Submission of Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: July 15, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices
and Radiological Health.
[FR Doc. 2011–18387 Filed 7–20–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
wreier-aviles on DSKDVH8Z91PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Cystic Fibrosis, Lung Fibrosis, and
Lung Innate Immunity Applications.
Date: August 8, 2011.
Time: 9 a.m. to 12 p.m.
VerDate Mar<15>2010
15:00 Jul 20, 2011
Jkt 223001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Everett E Sinnett, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2178,
MSC 7818, Bethesda, MD 20892, 301–435–
1016, sinnett@nih.gov.
This notice is being published less than
15 days prior to the meeting due to the
timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Date: August 23, 2011.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Rass M Shayiq, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 2182,
MSC 7818, Bethesda, MD 20892, (301) 435–
2359, shayiqr@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 15, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–18418 Filed 7–20–11; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2011–18420 Filed 7–20–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroimaging.
Date: August 9, 2011.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call)
Contact Person: Eduardo A Montalvo, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Special Emphasis Panel.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases
Diabetes Mellitus Interagency
Coordinating Committee; Notice of
Meeting
The Diabetes Mellitus Interagency
Coordinating Committee (DMICC) will
hold a meeting on August 1, 2011, from
8:30 a.m. to 11:30 p.m. at the Bethesda
Marriott Suites, 6711 Democracy Blvd,
Bethesda, MD 20817. The meeting is
open to the public but attendance is
limited to space available. Non-Federal
individuals planning to attend the
meeting should notify the Contact
Person listed on this notice at least 2
days prior to the meeting. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should inform the
Contact Person listed below at least 10
days in advance of the meeting.
The DMICC facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
members to learn about and discuss
current and future diabetes programs in
DMICC member organizations and to
identify opportunities for collaboration.
The August 1, 2011, DMICC meeting
will discuss ‘‘Guides and Guidelines.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the Contact
Person listed on this notice at least 10
E:\FR\FM\21JYN1.SGM
21JYN1
Federal Register / Vol. 76, No. 140 / Thursday, July 21, 2011 / Notices
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present
oral comments and presentations will be
limited to a maximum of five minutes.
Both printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first come, first serve basis.
A registration link and information
about the DMICC meeting will be
available on the DMICC Web site:
https://www.diabetescommittee.gov.
Members of the public who would like
to receive e-mail notification about
future DMICC meetings could register
on a listserv available on the same Web
site.
For further information concerning
this meeting contact Dr. Sanford
Garfield, Executive Secretary of the
Diabetes Mellitus Interagency
Coordinating Committee, National
Institute of Diabetes and Digestive and
Kidney Diseases, 6707 Democracy
Boulevard, Room 654, MSC 5460,
Bethesda, MD 20892–5460, Telephone:
301–594–8803 FAX: 301–402–6271, Email: dmicc@mail.nih.gov.
Dated: July 13, 2011.
Sanford Garfield,
Executive Secretary, DMICC, Division of
Diabetes, Endocrinology and Metabolic
Diseases, NIDDK, National Institutes of
Health.
[FR Doc. 2011–18422 Filed 7–20–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
wreier-aviles on DSKDVH8Z91PROD with NOTICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
VerDate Mar<15>2010
15:00 Jul 20, 2011
Jkt 223001
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Networking Suicide
Prevention Hotlines—Evaluation of the
Lifeline Policies for Helping Callers at
Imminent Risk (NEW)
This proposed project is a new data
collection that builds on previously
approved data collection activities
[Evaluation of Networking Suicide
Prevention Hotlines Follow-Up
Assessment (OMB No. 0930–0274) and
Call Monitoring of National Suicide
Prevention Lifeline Form (OMB No.
0930–0275)]. This new data collection is
an effort to advance the understanding
of crisis hotline utilization and its
impact. The Substance Abuse and
Mental Health Services
Administration’s (SAMHSA), Center for
Mental Health Services (CMHS) funds a
National Suicide Prevention Lifeline
Network (‘‘Lifeline’’), consisting of a
toll-free telephone number that routes
calls from anywhere in the United
States to a network of local crisis
centers. In turn, the local centers link
callers to local emergency, mental
health, and social service resources.
The overarching purpose of the
proposed Evaluation of the Lifeline
Policies for Helping Callers at Imminent
Risk is to implement data collection to
evaluate hotline counselors’
management of imminent risk callers
and third party callers concerned about
persons at imminent risk, and counselor
adherence to Lifeline Policies and
Guidelines for Helping Callers at
Imminent Risk of Suicide. Specifically,
the Evaluation of the Lifeline Policies
for Helping Callers at Imminent Risk
will collect data, using an imminent risk
form, to inform the network’s
knowledge of the extent to which
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
43695
counselors are aware of and being
guided by the Lifeline’s imminent risk
guidelines; counselors’ definitions of
imminent risk; the rates of active rescue
of imminent risk callers; types of rescue;
barriers to intervention; and the
circumstances in which active rescue is
initiated, including the caller’s
agreement to receive the intervention.
Clearance is being requested for one
activity to assess the knowledge,
actions, and practices of counselors to
aid callers who are determined to be at
imminent risk for suicide and who may
require active rescue. This evaluation
will allow researchers to examine and
understand the actions taken by
counselors to aid imminent risk callers,
the need for active rescue, and,
ultimately, to improve the delivery of
crisis hotline services to imminent risk
callers. A total of eight centers will
participate in this evaluation. Thus,
SAMHSA is requesting OMB review and
approval of the National Suicide
Prevention Lifeline—Imminent Risk
Form. This activity is distinct from the
Crisis Center Survey data collection,
which targets the entire network of
crisis centers and focuses on a different
domain of questions (specifically, the
makeup, strengths, and needs of crisis
centers.) The information gathered from
the Crisis Center Survey cannot provide
a profile of imminent risk callers or
details about interventions with
imminent risk or third party callers.
Crisis counselors at eight participating
centers will record information
discussed with imminent risk callers on
the Imminent Risk Form, which does
not require direct data collection from
callers. As with previously approved
evaluations, callers will maintain
anonymity. Counselors will be asked to
complete the form for 100% of
imminent risk callers to the eight
centers participating in the evaluation.
This form requests information in 14
content areas, each with multiple subitems and response options. Response
options include open-ended, yes/no,
Likert-type ratings, and multiple choice/
check all that apply. The form also
requests demographic information on
the caller, the identification of the
center and counselor submitting the
form, and the date of the call.
Specifically, the form is divided into the
following sections: (1) Call type, (2)
gender, (3) age, (4) suicidal desire, (5)
suicidal intent, (6) suicidal capability,
(7) buffers to suicide, (8) interventions
agreed to by caller or implemented by
counselor without consent, (9) whether
imminent risk was reduced enough such
that active rescue was not needed, (10)
interventions for third party callers
calling about a person at imminent risk,
E:\FR\FM\21JYN1.SGM
21JYN1
]]>Agencies
[Federal Register Volume 76, Number 140 (Thursday, July 21, 2011)]
[Notices]
[Pages 43694-43695]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-18422]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
Diabetes Mellitus Interagency Coordinating Committee; Notice of Meeting
The Diabetes Mellitus Interagency Coordinating Committee (DMICC)
will hold a meeting on August 1, 2011, from 8:30 a.m. to 11:30 p.m. at
the Bethesda Marriott Suites, 6711 Democracy Blvd, Bethesda, MD 20817.
The meeting is open to the public but attendance is limited to space
available. Non-Federal individuals planning to attend the meeting
should notify the Contact Person listed on this notice at least 2 days
prior to the meeting. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should inform the Contact Person listed below at least
10 days in advance of the meeting.
The DMICC facilitates cooperation, communication, and collaboration
on diabetes among government entities. DMICC meetings, held several
times a year, provide an opportunity for members to learn about and
discuss current and future diabetes programs in DMICC member
organizations and to identify opportunities for collaboration. The
August 1, 2011, DMICC meeting will discuss ``Guides and Guidelines.''
Any member of the public interested in presenting oral comments to
the Committee should notify the Contact Person listed on this notice at
least 10
[[Page 43695]]
days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present oral
comments and presentations will be limited to a maximum of five
minutes. Both printed and electronic copies are requested for the
record. In addition, any interested person may file written comments
with the Committee by forwarding their statement to the Contact Person
listed on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person. Because of time constraints for
the meeting, oral comments will be allowed on a first come, first serve
basis.
A registration link and information about the DMICC meeting will be
available on the DMICC Web site: https://www.diabetescommittee.gov.
Members of the public who would like to receive e-mail notification
about future DMICC meetings could register on a listserv available on
the same Web site.
For further information concerning this meeting contact Dr. Sanford
Garfield, Executive Secretary of the Diabetes Mellitus Interagency
Coordinating Committee, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Room 654, MSC 5460,
Bethesda, MD 20892-5460, Telephone: 301-594-8803 FAX: 301-402-6271, E-
mail: dmicc@mail.nih.gov.
Dated: July 13, 2011.
Sanford Garfield,
Executive Secretary, DMICC, Division of Diabetes, Endocrinology and
Metabolic Diseases, NIDDK, National Institutes of Health.
[FR Doc. 2011-18422 Filed 7-20-11; 8:45 am]
BILLING CODE 4140-01-P
